Therapeutic Advances in Respiratory Disease (Jun 2024)

Prescriptions of opioid-containing drugs in patients with chronic cough

  • Michael Weiner,
  • Ziyue Liu,
  • Jonathan Schelfhout,
  • Paul Dexter,
  • Anna R. Roberts,
  • Ashley Griffith,
  • Vishal Bali,
  • Jessica Weaver

DOI
https://doi.org/10.1177/17534666241259373
Journal volume & issue
Vol. 18

Abstract

Read online

Background: Chronic cough (CC) affects about 10% of adults, but opioid use in CC is not well understood. Objectives: To determine the use of opioid-containing cough suppressant (OCCS) prescriptions in patients with CC using electronic health records. Design: Retrospective cohort study. Methods: Through retrospective analysis of Midwestern U.S. electronic health records, diagnoses, prescriptions, and natural language processing identified CC – at least three medical encounters with cough, with 56–120 days between first and last encounter – and a ‘non-chronic cohort’. Student’s t -test, Pearson’s chi-square, and zero-inflated Poisson models were used. Results: About 20% of 23,210 patients with CC were prescribed OCCS; odds of an OCCS prescription were twice as great in CC. In CC, OCCS drugs were ordered in 38% with Medicaid insurance and 15% with commercial insurance. Conclusion: Findings identify an important role for opioids in CC, and opportunity to learn more about the drugs’ effectiveness.